We tested the hypothesis that during decrements in plasma glucose concentration, symptoms of hypoglycemia may occur at higher glucose concentrations in patients with poorly controlled insulin-dependent diabetes mellitus than in persons without diabetes. Symptoms of hypoglycemia and counterregulatory neuroendocrine responses were quantified during hypoglycemic and euglycemic clamp studies in eight patients with insulin-dependent diabetes mellitus selected because their hemoglobin A1 levels were above 10 percent. These data were compared with similar observations in 10 nondiabetic subjects studied previously. Glycemic thresholds--the plasma glucose concentrations during each hypoglycemic clamp study at which a given symptom or biochemical measurement first exceeded its 95 percent confidence interval determined in the euglycemic clamp studies--were calculated for each variable. The mean (+/- SE) glycemic threshold for the symptoms of hypoglycemia was 4.3 +/- 0.3 mmol per liter (78 +/- 5 mg per deciliter) in patients with poorly controlled diabetes--significantly higher (P less than 0.001) than the value of 2.9 +/- 0.1 mmol per liter (53 +/- 2 mg per deciliter) in subjects without diabetes. The mean glycemic thresholds for growth hormone, epinephrine, and cortisol secretions were not significantly different in the two groups. Thus, during decreases in the plasma glucose concentration, patients with poorly controlled insulin-dependent diabetes mellitus may experience symptoms of hypoglycemia at higher plasma glucose concentrations than persons without diabetes. The mechanism underlying this observation remains to be defined.
Source Information
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.
This article has been cited by other articles:
Pearson, T.
(2008). Glucagon as a Treatment of Severe Hypoglycemia: Safe and Efficacious but Underutilized. The Diabetes Educator
34: 128-134
[Abstract][Full Text]
Stork, A. D.M., van Haeften, T. W., Veneman, T. F.
(2007). The Decision Not to Drive During Hypoglycemia in Patients With Type 1 and Type 2 Diabetes According to Hypoglycemia Awareness. Diabetes Care
30: 2822-2826
[Abstract][Full Text]
White, J. R. Jr.
(2007). The Contribution of Medications to Hypoglycemia Unawareness. Diabetes Spectr.
20: 77-80
[Full Text]
Kearney, T, Dang, C
(2007). Diabetic and endocrine emergencies. Postgrad. Med. J.
83: 79-86
[Abstract][Full Text]
Briscoe, V. J., Davis, S. N.
(2006). Hypoglycemia in Type 1 and Type 2 Diabetes: Physiology, Pathophysiology, and Management. Clin. Diabetes
24: 115-121
[Abstract][Full Text]
American Diabetes Association Workgroup on Hypogly,
(2005). Defining and Reporting Hypoglycemia in Diabetes: A report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care
28: 1245-1249
[Full Text]
de Galan, B. E., Tack, C. J., Willemsen, J. J., Sweep, C. G. J., Smits, P., Lenders, J. W. M.
(2004). Plasma Metanephrine Levels Are Decreased in Type 1 Diabetic Patients with a Severely Impaired Epinephrine Response to Hypoglycemia, Indicating Reduced Adrenomedullary Stores of Epinephrine. J. Clin. Endocrinol. Metab.
89: 2057-2061
[Abstract][Full Text]
Cryer, P. E., Davis, S. N., Shamoon, H.
(2003). Hypoglycemia in Diabetes. Diabetes Care
26: 1902-1912
[Abstract][Full Text]
Segel, S. A., Paramore, D. S., Cryer, P. E.
(2002). Hypoglycemia-Associated Autonomic Failure in Advanced Type 2 Diabetes. Diabetes
51: 724-733
[Abstract][Full Text]
Cryer, P. E.
(2001). Hypoglycemia-associated autonomic failure in diabetes. Am. J. Physiol. Endocrinol. Metab.
281: E1115-E1121
[Abstract][Full Text]
Rosenthal, J. M., Amiel, S. A., Yaguez, L., Bullmore, E., Hopkins, D., Evans, M., Pernet, A., Reid, H., Giampietro, V., Andrew, C. M., Suckling, J., Simmons, A., Williams, S. C.R.
(2001). The Effect of Acute Hypoglycemia on Brain Function and Activation: A Functional Magnetic Resonance Imaging Study. Diabetes
50: 1618-1626
[Abstract][Full Text]
Burge, M. R., Schmitz-Fiorentino, K., Fischette, C., Qualls, C. R., Schade, D. S.
(1998). A Prospective Trial of Risk Factors for Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Mellitus. JAMA
279: 137-143
[Abstract][Full Text]
Boyle, P. J., Kempers, S. F., O'Connor, A. M., Nagy, R. J.
(1995). Brain Glucose Uptake and Unawareness of Hypoglycemia in Patients with Insulin-Dependent Diabetes Mellitus. NEJM
333: 1726-1732
[Abstract][Full Text]
(1988). HYPOGLYCEMIC SYMPTOMS OCCUR AT HIGHER GLUCOSE LEVELS IN DIABETICS THAN IN NONDIABETICS. JWatch General
1988: 2-2
[Full Text]
Havlin, C. E., Cryer, P. E.
(1988). Hypoglycemia: The Limiting Factor in the Management of Insulin-Dependent Diabetes Mellitus. The Diabetes Educator
14: 407-411
Previous
